Systemic Juvenile Idiopathic Arthritis

• FDA approval · 2026-01-14
  FDA Approved: AVTOZMA — Supplemental Application (CELLTRION USA, Inc.)

  FDA approves a supplemental application for AVTOZMA (tocilizumab) filed by Celltrion USA, Inc.

• FDA approval · 2025-12-10
  FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc.

• FDA approval · 2025-05-12
  FDA Approved: TYENNE — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for TYENNE (tocilizumab-azg) from Fresenius Kabi USA, LLC.

• FDA approval · 2025-03-13
  FDA Approved: TYENNE — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for TYENNE (tocilizumab-AAZG) from Fresenius Kabi USA, LLC.

• FDA approval · 2024-03-05
  FDA Approved: TYENNE — Original Application (Fresenius Kabi USA, LLC)

  FDA approved TYENNE (tocilizumab-AAZG) from Fresenius Kabi USA, LLC under an Original Application.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2021-10-22
  FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Actemra (tocilizumab) from Genentech, expanding its labeling and/or indications. The action conf…

• FDA approval · 2019-06-11
  FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Actemra (tocilizumab) filed by Genentech, Inc., resulting in an approved update to the product's…

• FDA approval · 2017-05-22
  FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. The supplementary filing status is AP (approv…

• FDA approval · 2016-09-23
  FDA Approved: ILARIS — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for ILARIS (canakinumab) submitted by Novartis Pharmaceuticals Corporation, resulting in an upda…

• FDA approval · 2014-11-13
  FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

  The FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. This action involves an approved product …

• FDA approval · 2012-08-13
  FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Actemra (tocilizumab) submitted by Genentech, broadening its labeling.